Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Theca Cells | 5 | 2012 | 18 | 1.620 |
Why?
|
| Chorionic Gonadotropin | 3 | 2012 | 127 | 1.060 |
Why?
|
| Cellulose | 2 | 2024 | 24 | 1.000 |
Why?
|
| Biomass | 1 | 2024 | 22 | 0.950 |
Why?
|
| Plant Leaves | 1 | 2024 | 60 | 0.930 |
Why?
|
| Small Molecule Libraries | 6 | 2024 | 195 | 0.880 |
Why?
|
| Mammary Glands, Animal | 2 | 2019 | 617 | 0.620 |
Why?
|
| DNA | 8 | 2024 | 3036 | 0.600 |
Why?
|
| Insulin | 2 | 2012 | 1432 | 0.500 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 692 | 0.480 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2018 | 550 | 0.470 |
Why?
|
| Tamoxifen | 1 | 2018 | 873 | 0.460 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 379 | 0.450 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 2105 | 0.420 |
Why?
|
| Polyesters | 2 | 2024 | 68 | 0.410 |
Why?
|
| Luteinizing Hormone | 1 | 2012 | 165 | 0.400 |
Why?
|
| Androgens | 2 | 2012 | 506 | 0.390 |
Why?
|
| beta-Lactamase Inhibitors | 2 | 2023 | 62 | 0.380 |
Why?
|
| Cyclic AMP | 1 | 2010 | 376 | 0.330 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 40 | 0.330 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2012 | 1537 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2450 | 0.320 |
Why?
|
| Transcriptome | 1 | 2018 | 1960 | 0.320 |
Why?
|
| beta-Lactamases | 4 | 2024 | 223 | 0.320 |
Why?
|
| Signal Transduction | 4 | 2023 | 12056 | 0.310 |
Why?
|
| Escherichia coli | 3 | 2024 | 1300 | 0.310 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2024 | 41 | 0.300 |
Why?
|
| Tensile Strength | 2 | 2024 | 76 | 0.280 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 3654 | 0.250 |
Why?
|
| Proteins | 2 | 2019 | 2034 | 0.250 |
Why?
|
| Sansevieria | 1 | 2024 | 1 | 0.230 |
Why?
|
| Contraceptive Agents, Male | 1 | 2024 | 26 | 0.230 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2024 | 240 | 0.230 |
Why?
|
| Contraception | 1 | 2024 | 63 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 2150 | 0.220 |
Why?
|
| Sirolimus | 3 | 2012 | 829 | 0.220 |
Why?
|
| Rats | 5 | 2012 | 6430 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2056 | 0.210 |
Why?
|
| Biofilms | 1 | 2024 | 204 | 0.210 |
Why?
|
| Phosphoproteins | 3 | 2012 | 1130 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2018 | 5677 | 0.200 |
Why?
|
| Copper | 1 | 2023 | 165 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 9042 | 0.200 |
Why?
|
| Ribosomal Protein S6 | 2 | 2012 | 44 | 0.200 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2012 | 266 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 133 | 0.190 |
Why?
|
| Androstenedione | 2 | 2012 | 18 | 0.190 |
Why?
|
| Corchorus | 1 | 2020 | 2 | 0.190 |
Why?
|
| Composite Resins | 1 | 2020 | 6 | 0.190 |
Why?
|
| Egg Shell | 1 | 2020 | 4 | 0.190 |
Why?
|
| Glass | 1 | 2020 | 33 | 0.190 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2012 | 36 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 1275 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 3193 | 0.180 |
Why?
|
| Nanostructures | 1 | 2020 | 98 | 0.170 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2019 | 5 | 0.170 |
Why?
|
| Phosphorylation | 3 | 2012 | 4911 | 0.170 |
Why?
|
| Nitro Compounds | 1 | 2019 | 24 | 0.160 |
Why?
|
| Animals | 11 | 2024 | 61671 | 0.160 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2023 | 499 | 0.160 |
Why?
|
| Amines | 1 | 2019 | 82 | 0.160 |
Why?
|
| Gene Silencing | 2 | 2012 | 823 | 0.160 |
Why?
|
| Boron Compounds | 1 | 2019 | 72 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 4966 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 22 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 506 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2010 | 5399 | 0.130 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2012 | 109 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 2192 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 1196 | 0.130 |
Why?
|
| Binding Sites | 1 | 2019 | 2247 | 0.120 |
Why?
|
| Catalysis | 3 | 2020 | 245 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 1712 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2012 | 7221 | 0.120 |
Why?
|
| Peptides | 1 | 2020 | 1503 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1125 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 1092 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 16238 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2012 | 2082 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 2454 | 0.110 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 841 | 0.110 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2012 | 8 | 0.100 |
Why?
|
| Colforsin | 1 | 2012 | 64 | 0.100 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 79 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2024 | 305 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 257 | 0.100 |
Why?
|
| Female | 10 | 2024 | 149013 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 194 | 0.100 |
Why?
|
| Cattle | 1 | 2012 | 830 | 0.090 |
Why?
|
| Cyclin D3 | 1 | 2010 | 26 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 2351 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2018 | 4330 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 382 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 2177 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2012 | 1806 | 0.090 |
Why?
|
| Gene Library | 2 | 2023 | 351 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 2359 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2012 | 394 | 0.090 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 3 | 0.080 |
Why?
|
| Aminoglutethimide | 1 | 2009 | 13 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1075 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3925 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 40 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 4103 | 0.080 |
Why?
|
| Genomics | 1 | 2019 | 2834 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 687 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 142 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 808 | 0.080 |
Why?
|
| Mice | 4 | 2024 | 35449 | 0.080 |
Why?
|
| Metformin | 1 | 2012 | 396 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 589 | 0.080 |
Why?
|
| RNA Interference | 1 | 2012 | 1383 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 294 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5143 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4796 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 659 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2009 | 2312 | 0.060 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 14 | 0.060 |
Why?
|
| Flowers | 1 | 2024 | 7 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 32 | 0.060 |
Why?
|
| beta-Lactams | 1 | 2023 | 63 | 0.060 |
Why?
|
| Sphingomyelins | 1 | 2023 | 28 | 0.060 |
Why?
|
| Alloys | 1 | 2023 | 29 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 20 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 138 | 0.050 |
Why?
|
| Electrodes | 1 | 2023 | 132 | 0.050 |
Why?
|
| Penicillins | 1 | 2023 | 170 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2022 | 237 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 84 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 1897 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 978 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2024 | 656 | 0.050 |
Why?
|
| Water | 1 | 2024 | 386 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 354 | 0.050 |
Why?
|
| Methacrylates | 1 | 2020 | 21 | 0.050 |
Why?
|
| Powders | 1 | 2020 | 26 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 613 | 0.050 |
Why?
|
| Endometriosis | 1 | 2024 | 231 | 0.050 |
Why?
|
| Filtration | 1 | 2020 | 87 | 0.050 |
Why?
|
| Elasticity | 1 | 2020 | 136 | 0.050 |
Why?
|
| Materials Testing | 1 | 2020 | 119 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 189 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2010 | 6353 | 0.040 |
Why?
|
| Cyclization | 1 | 2020 | 19 | 0.040 |
Why?
|
| Buffers | 1 | 2020 | 42 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 1009 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 1076 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2020 | 137 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2022 | 329 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 387 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 56 | 0.040 |
Why?
|
| Humans | 7 | 2024 | 270884 | 0.040 |
Why?
|
| Time Factors | 1 | 2012 | 13000 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 790 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2009 | 2911 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2019 | 525 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 2057 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 2472 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 271 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 497 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 884 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 600 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 15873 | 0.010 |
Why?
|
| Male | 2 | 2024 | 128379 | 0.010 |
Why?
|